COVID Accepted for Coverage in Scopus

We are pleased to announce that COVID (ISSN: 2673-8112) has been accepted for coverage in the Scopus indexing database in April 2024. We would like to extend our sincerest gratitude to all of the authors, reviewers, and editors who have contributed to this journal and helped us accomplish this achievement.

COVID is an international, peer-reviewed, and open access journal that publishes original papers on all aspects of coronaviruses, from basic molecular and clinical research to COVID-related public health, physical and psychological health, and economic and environmental impact studies, as well as on all other aspects affected by coronaviruses. The journal’s aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.

We would like to take this opportunity to invite you to submit your research to the journal. We warmly welcome you to consider COVID as a platform for publishing your work. If you have a paper concerning any topic within the scope of the journal, please submit it via the journal’s website: https://www.mdpi.com/journal/COVID.